Učitavanje...
Mesenchymal stromal cell delivery of oncolytic immunotherapy improves CAR-T cell antitumor activity
The immunosuppressive tumor microenvironment (TME) is a formidable barrier to the success of adoptive cell therapies for solid tumors. Oncolytic immunotherapy with engineered adenoviruses (OAd) may disrupt the TME by infecting tumor cells, as well as surrounding stroma, to improve the functionality...
Spremljeno u:
| Izdano u: | Mol Ther |
|---|---|
| Glavni autori: | , , , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
American Society of Gene & Cell Therapy
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8116608/ https://ncbi.nlm.nih.gov/pubmed/33571680 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ymthe.2021.02.004 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|